scholarly journals Cognitive Loss in Dementia With Lewy Bodies and Alzheimer Disease

1998 ◽  
Vol 55 (12) ◽  
pp. 1547 ◽  
Author(s):  
Tatsuo Shimomura ◽  
Etsuro Mori ◽  
Hikari Yamashita ◽  
Toru Imamura ◽  
Nobutsugu Hirono ◽  
...  
Author(s):  
Lynn Marie Trotti ◽  
Donald L. Bliwise ◽  
Glenda L. Keating ◽  
David B. Rye ◽  
William T. Hu

Background/Aims: Hypocretin promotes wakefulness and modulates REM sleep. Alterations in the hypocretin system are increasingly implicated in dementia. We evaluated relationships among hypocretin, dementia biomarkers, and sleep symptoms in elderly participants, most of whom had dementia. Methods: One-hundred twenty-six adults (mean age 66.2 ± 8.4 years) were recruited from the Emory Cognitive Clinic. Diagnoses were Alzheimer disease (AD; n = 60), frontotemporal dementia (FTD; n = 21), and dementia with Lewy bodies (DLB; n = 20). We also included cognitively normal controls (n = 25). Participants and/or caregivers completed sleep questionnaires and lumbar puncture was performed for cerebrospinal fluid (CSF) assessments. Results: Except for sleepiness (worst in DLB) and nocturia (worse in DLB and FTD) sleep symptoms did not differ by diagnosis. CSF hypocretin concentrations were available for 87 participants and normal in 70, intermediate in 16, and low in 1. Hypocretin levels did not differ by diagnosis. Hypocretin levels correlated with CSF total τ levels only in men (r = 0.34; p = 0.02). Lower hypocretin levels were related to frequency of nightmares (203.9 ± 29.8 pg/mL in those with frequent nightmares vs. 240.4 ± 46.1 pg/mL in those without; p = 0.05) and vivid dreams (209.1 ± 28.3 vs. 239.5 ± 47.8 pg/mL; p = 0.014). Cholinesterase inhibitor use was not associated with nightmares or vivid dreaming. Conclusion: Hypocretin levels did not distinguish between dementia syndromes. Disturbing dreams in dementia patients may be related to lower hypocretin concentrations in CSF.


2017 ◽  
Author(s):  
David Knopman

There are a relatively small number of disorders that account for the majority of dementia in the elderly that is not Alzheimer disease (AD): cerebrovascular disease, Lewy body disease (α-synucleinopathies), and the frontotemporal lobar degenerations. Cerebrovascular disease and Lewy body disease account for most non-AD dementia among persons in the eighth decade of life and beyond. These two frequently co-occur with AD but can occur in their pure forms rarely (in the case of dementia associated with cerebrovascular disease) or more commonly (in the case of Lewy body disease). There is no one cognitive or behavioral syndrome associated with cerebrovascular disease; however, attempts to isolate a common theme suggest that cognitive slowing is typical of cerebrovascular contributions to cognitive impairment. Cerebrovascular pathology relevant to cognitive impairment accumulates subclinically more commonly than it causes acute, strokelike declines in cognition. Dementia with Lewy bodies is a multidimensional disorder that includes a nonamnestic dementia, Parkinson disease or at least some parkinsonian features, a disorder of sleep and wakefulness, autonomic disturbances, and depression. The disorders of sleep prominently include rapid eye movement sleep behavior disorder, excessive daytime sleepiness, visual hallucinations, and marked fluctuations in level of alertness. The frontotemporal lobar degenerations are nearly as common as causes of dementia in persons under age 65 as is AD. The group of disorders includes two cognitive syndromes (primary progressive aphasia and behavior variant frontotemporal dementia) and two neuropathologic subtypes (tauopathy and TDP43 proteinopathy) and is associated with three major autosomal dominant genetic mutations (in MAPT, GRN, and C9ORF72). Key words: dementia with Lewy bodies, frontotemporal lobar degenerations, vascular cognitive impairment


1997 ◽  
Vol 56 (5) ◽  
pp. 499-508 ◽  
Author(s):  
WILLIAM SAMUEL ◽  
MICHAEL ALFORD ◽  
C. RICHARD HOFSTETTER ◽  
LAWRENCE HANSEN

2019 ◽  
Vol 33 (3) ◽  
pp. 279-281
Author(s):  
Noa Bregman ◽  
Gitit Kavé ◽  
Anat Mirelman ◽  
Avner Thaler ◽  
Mali Gana Weisz ◽  
...  

2016 ◽  
Vol 24 (2) ◽  
pp. 136-143 ◽  
Author(s):  
Elijah Mak ◽  
Li Su ◽  
Guy B. Williams ◽  
Rosie Watson ◽  
Michael Firbank ◽  
...  

Author(s):  
Paula Garcia-Esparcia ◽  
Daniela Diaz-Lucena ◽  
Marina Ainciburu ◽  
Benjamin Torrejón-Escribano ◽  
Margarita Carmona ◽  
...  

2017 ◽  
Vol 163 ◽  
pp. 163-166 ◽  
Author(s):  
Mehrshad Abbasi ◽  
Nafise Ghalandari ◽  
Saeed Farzanefar ◽  
Vajiheh Aghamollaii ◽  
Mona Ahmadi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document